Cannabis	Cannabis sativa L.
1-AG	1-arachidonoylglycerol
2-AG	2-arachidonoylglycerol
2-MAGs	2-monoacylglycerols
5HT2Ar	Serotoninergic 2A receptor
ABA	Activity-based anorexia
ABHD12	α/β-hydrolase domain 12
ABHD6	α/β-hydrolase domain 6
ACC	Anterior cingulate cortex
AD	Anxiety disorders
ADHD	Attention deficit hyperactivity disorder
AEA	Anandamide
AMY	Amygdala
AN	Anorexia Nervosa
ASD	Autism spectrum disorder
AUD	Alcohol use disorders
BED	Binge eating disorder
BMI	Body mass index
BN	Bulimia Nervosa
CaUD	Cannabis Use Disorder
CB1r	Cannabinoid receptor 1
CB2r	Cannabinoid receptor 2
CBD	Cannabidiol
CNR1	Gene encoding cannabinoid receptor 1
CNR2	Gene encoding cannabinoid receptor 2
CNR2A	Gene encoding cannabinoid receptor 2 isoform A
CNR2B	Gene encoding cannabinoid receptor 2 isoform B
CNS	Central Nervous System
CPP	Conditioned Place Preference
CoUD	Cocaine use disorder
CpG	cytosine-guanine dinucleotide
CPP	conditioned place preference
CPu	Caudate putamen
CSF	Cerebrospinal fluid
d8-2AG	Deuterium-labeled 2AG
d8-AA	Deuterium-labeled AA
D1	Dopamine receptor 1
DA	Dopamine
DAGL	Diacylglycerol lipase
DAT	Dopamine transporter
DD	Depressive disorders
DLPFC	Dorsolateral frontal cortex
DNA	Desoxyribonucleic acid
DSM-V	Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
EA	Eating disorders
eCBs	Endocannabinoids
ECS	Endocannabinoid system
EMT	Endocannabinoid Membrane Transporter
EOPF	Octylphosphonofluoridate
FAAH	fatty acid amide hydrolase
FD	Functional dyspepsia
GABA	γ-aminobutyric acid
GAD	Generalized anxiety disorder
GPCRs	Gq protein-coupled receptors
GPR55r	G protein coupled receptor 55
GTPγS	GTPgammaS o Guanosine 5′-O-(γ-thio) triphosphate
GWAS	Genome-wide association studies
HIPP	Hippocampus
HPLC-MS/MS	High-performance liquid chromatography-tandem mass spectrometry
HYP	Hypothalamus
LC	Locus coeruleus
LC-MS/MS	Liquid chromatography-tandem mass spectrometry
MAGs	Monoacylglycerols
MAGL	Monoacylglycerol lipase
MGLL	Gene encoding monoacylglycerol lipase
mRNA	Ribonucleic acid messenger
MSDB	Medial septum-diagonal band of Broca area
NAcc	Nucleus accumbens
NAEs	N-acyl-ethanolamines
NAPE-PLD	N-acylphosphatidylethanolamine specific phospholipase D
NarPE	N-arachidonoyl phosphatidylethanolamine
NGS	Next-generation or massively parallel sequencing
NUD	Nicotine use disorder
OB	Obesity
OEA	Oleoyl-ethanolamide
OFC	Orbitofrontal cortex
ON	Olfactory neuroepithelium
OUD	Opioid Use Disorder
PPARα	Proliferator-activated receptor-α
PBMCs	Peripheral blood mononuclear cells
PCC	Posterior cingulate cortex
PCR	Polymerase chain reaction
PEA	Palmitoyl-ethanolamide
PET	Positron emission tomography
PFC	Prefrontal cortex
PLB	Placebo
PPI	Prepulse inhibition
PT	Putamen
PTMs	Post-translational modifications
PTSD	Post-traumatic stress disorder
Q	Glutamine
q-PCR	Quantitative Real-Time Polymerase chain reaction
R	Arginine
SCUD	Synthetic cannabinoid use disorder
SHR	Spontaneously hypertensive rats
SN	Substantia nigra
SNPs	Single nucleotide polymorphisms
STG	Superior temporal gyrus
STRs	Short sequence repeats
SUD	Substance use disorders
THC	Δ9-tetrahydrocannabinol
TLC	Thin-layer chromatography
UFLC-MS/MS	Ultra-fast liquid chromatography coupled with tandem mass spectrometry
UPLC-MS/MS	Ultra-performance liquid chromatography coupled to mass spectrometry
UPLC-TOF/MS	Ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry
VS	Ventral striatum
WES	Whole-exome sequencing
WGS	Whole-genome sequencing
WKY	Wistar Kyoto rats